Appropriate use of immune checkpoint inhibitors and immunotherapy differs in adults with unresectable, metastatic cutaneous ...

The FDA biologics head Dr Vinay Prasad will step down in April following a tenure with controversial policy shifts and vaccine restrictions.

A total of 92% of patients rated their satisfaction with phenol-croton peels as high, as rated as a score of 4 or 5 on the GSI.

Doxycycline PEP reduces chlamydia risk but is associated with higher gonorrhea odds in a real-world study of a diverse clinic population.

Eighteen states adopted cost-cutting changes to AIDS Drug Assistance Programs, potentially increasing HIV transmission and drug resistance.

Use of IPL therapy long-term is effective for improving facial outcomes in patients with rosacea, acne, or cosmetic concerns.

Risankizumab is effective through 2.5 years of treatment among patients with psoriasis, with most patients achieving rapid and sustained response.

The CDC's 2024 data showed a slight decline in US maternal mortality from 2023, continuing a downward trend after the pandemic.

Use of a clinician-facing dashboard combined with a best practice alert helped increase rates of HLA-B*58:01 genetic testing among patients prescribed allopurinol.

An expected review of the United States’ measles elimination status has been postponed by seven months. The meeting, originally scheduled for mid-April, will ...

The FDA has accepted a Biologics License Application for imsidolimab to treat generalized pustular psoriasis, a rare inflammatory skin condition.

Litifilimab for 16 weeks was associated with improvements across various skin-specific outcomes compared with placebo in patients with CLE.